Daily Hong Kong Stock Market News Briefing (April 3, Thursday)

USHK News
2025.04.03 01:09
  1. Dazhu CNC: Research and demonstration of the issuance of overseas securities (H shares) and listing matters.

  2. WuXi AppTec (02359.HK): Sold 50.8 million shares of WuXi AppTec, accounting for approximately 4.23% of the total share capital, with a transaction amount of approximately HKD 2.178 billion.

  3. HSBC downgraded the H share rating of China Southern Airlines (01055.HK) to reduce holdings, with a target price of HKD 3.

  4. Tencent Holdings (00700.HK): Repurchased HKD 17.1 billion in the first quarter, exceeding the level of the same period last year.

  5. Alibaba (09988.HK): Repurchased a total of 51 million ordinary shares at a total price of USD 600 million in the first quarter, with an remaining repurchase quota of USD 2.01 billion under the board-authorized share repurchase plan as of March 31, 2025.

  6. CSTONE PHARMA (02616.HK): Plans to place a total of 80 million placement shares at a placement price of HKD 2.933 per share, with estimated net proceeds of HKD 232 million, 90% of which will be used for assets in the group's "Pipeline 2.0".

  7. HENLIUS (02696.HK): The phase III clinical study of the recombinant anti-VEGF humanized monoclonal antibody injection HLX04-O for the treatment of wet age-related macular degeneration (wAMD) achieved its primary research endpoint